Google
 

Wednesday, August 27, 2008

UK : University of Nottingham PhD Studentship (Environmental Scientist/Engineer)

Nottingham Transportation Engineering Centre

Click here for Employer Profile

Scotland : University of Edinburgh Postdoctoral Research Fellow

Required to work in a team led by Professor Alistair Aitken in the School of Biological Sciences on a project funded by the Parkinson's Disease Society; to study how members of the 14-3-3 protein family and other proteins are involved in the protein aggregates that accumulate in the specific areas of the brain in Parkinson's disease, as well as other neurodegenerative disorders. You must have a PhD in relevant biological or biochemical discipline with a background in molecular cloning and with some experience in protein chemistry. Experience should also include manipulation of our expression clones into suitable vectors for protein production; liaison with the production facility and for affinity purification and co-purification of the protein complexes. Post is funded for up to 17 months.

Fixed Term: 17 months

Salary Scale: £28,290 - £33,780 pa

Vacancy reference: 3009718jw

Closing date: 16 September 2008

For further particulars https://www.jobs.ed.ac.uk/jobs/index.cfm?action=jobdet&jobid=3009718 and an application pack visit our website (www.jobs.ed.ac.uk) or telephone the recruitment line on 0131 650 2511.

Click here for Employer Profile

Monday, August 25, 2008

UK : Newcastle University PhD Studentship

Influence of Telomere Length and Statins on Lymphocyte Growth Kinetics in Patients with Coronary Heart Disease

Institute of Human Genetics

Supervisor(s): Professor Ioakim Spyridopoulos, Professor of Cardiovascular Gerontology
Institute: Institute of Human Genetics
Duration: 3 years, full time
Sponsor: Faculty of Medical Sciences, Newcastle University

Reference Code: IHG70

Background

Telomerase is a DNA polymerase that elongates the ends of chromosomes, which are formed by TTAGGG DNA repeats called telomeres. Telomeres are widely regarded as the internal biological clock of a living organism, and shorten by a few base pairs with every cell division. In addition, they are also crucial to maintaining chromosomal integrity. Overexpression or endogenously active telomerase in stem cells can counteract replicative telomere shortening. In vitro, telomere shortening can be accelerated by either loss of telomere capping proteins (i.e. TRF2), oxidative stress, or DNA damage, each leading to premature senescence. Age-related pathologies with short telomeres include infertility, impaired wound-healing and liver cirrhosis. Individuals with agecorrected shortage of leukocyte telomeres have a significantly higher risk of developing coronary heart disease or of dying from cardiovascular and infectious disease. Male individuals with shorter telomere length have an increased risk of developing coronary heart disease (CHD). This telomere-attributed risk is completely attenuated by treatment with pravastatin, an inhibitor of the HMG-CoA reductase.

Plan

Unexpected results from animal experiments have shown that critically short telomeres in the absence of telomerase activity lead to restricted atheroma progression, most likely due to impaired proliferation of both, lymphocytes and macrophages, an important step in atherosclerosis development. Statins have also been shown to inhibit lymphocyte proliferation in vitro via modification of the mevalonate pathway and hereby increase of isoprenoid intermediates. We have found previously in patients with CHD telomere shortening in the lymphocyte population to be far more pronounced than in myeloid cells. We have also generated pilot data showing that atorvastatin inhibits the enzyme telomerase in human lymphocytes. The goal of this study is to a) retrieve evidence from patients with CHD whether statin therapy attenuates telomerase activity in peripheral blood lymphocytes in vivo, b) influences in vitro growth kinetics of these cells, c) investigate a potential link between growth kinetics, oxidative stress and telomere length, and d) analyse the mechanism of telomerase-inhibition by statins in vitro.

Experimental Approach

A. In vivo study
1. Longitudinal study of 50 statin-naïve patients with stable coronary heart disease.
2. Isolation of lymphocyte subpopulations by FACS sorting.
3. Surface staining.
4. Measurement of telomere length by Flow-FISH.
5. Measurement of telomerase activity and oxidative stress in lymphocytes.
6. Determination of growth-kinetics in cultured lymphocytes.

B. In vitro experiments
1. Modulation of telomerase activity by statins.
2. Akt/Foxo3a pathway and telomerase inhibition
3. Dependence of statin-effect on interferon-γ.
4. Measurement of telomere length in long-term cultures.

Person Specification

Applicants should have a Master’s degree (MSc or MRes), or equivalent in a relevant subject. Applicants whose first language is not English must have IELTS 6.5, or equivalent.

Value of the Award and Eligibility
This studentship covers fees at the UK/EU rate and an annual stipend of £12,940. International students may apply but will be required to source additional funding to cover the cost of their fees.

How to Apply

To apply for the studentship please complete the University’s online postgraduate application form, quoting the reference number IHG70. You should select ‘PhD in the Faculty of Medical Sciences (full time) – Human Genetics’ and attach a CV and covering letter.

Early application is advised as this position will only be available until a suitable candidate is found.

Further Information

Please contact Professor Ioakim Spyridopoulos, ioakim.spyridopoulos@ncl.ac.uk, for further details.

Ireland : National University of Ireland, Galway PhD Studentship

Social Capital and Marine Resource Governance

Department of Economics

Further Details

UK : University of Surrey Joint PhD Studentship

Development of a Microbolometer for Microdosimetry of Ionisation Radiation

NPL-Surrey University Strategic Partnership

Further Details

Wales : Cardiff University PhD Studentship: Discovery of New Metal Oxide Catalysts for Clean Energy

Cardiff School of Chemistry

Click here for Employer Profile